NG
ELV icon

NatWest Group’s Elevance Health ELV Stock Holding History

NatWest Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,291
Closed -$2.34M – 592
2013
Q4 		$2.34M Buy
25,291
+4,561
+22% +$405K 0.06% 258
2013
Q3 		$1.73M Buy
+20,730
New +$1.78M 0.05% 282

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

NatWest Group's ELV Position: Q1 2014 in Review

NatWest Group sold out of Elevance Health (ELV) in Q1 2014, closing a stake of 25,291 shares — an estimated $2.34M sold.

NatWest Group first reported a position in ELV in Q3 2013 and held it in 2 quarters. The position peaked at $2.34M in Q4 2013. 662 funds tracked by Wall St. Rank hold ELV as of Q1 2014.

  • NatWest Group reported no remaining Elevance Health position as of Q1 2014 after selling out during the quarter.
  • NatWest Group sold 25,291 Elevance Health shares in Q1 2014, an estimated $2.34M.
  • NatWest Group first reported a position in Elevance Health in Q3 2013 and held it in 2 quarters.
  • NatWest Group's Elevance Health position peaked at $2.34M in Q4 2013.
  • 662 funds tracked by Wall St. Rank held Elevance Health as of Q1 2014.

Based on NatWest Group's 13F filing for Q1 2014, filed 15 May 2014.